RNU6ATAC24P

Across TCGA pan-cancer cohorts, RNU6ATAC24P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU6ATAC24P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNU6ATAC24P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6ATAC24P is over-expressed in tumor.

STAD, LUSC, and LIHC are the cancer types where RNU6ATAC24P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6ATAC24P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	II,III,IV	+0.540	.045	1	view →
LUSC	All	All	+0.316	.045	1	view →
LIHC	Female	All	+0.194	.045	1	view →
KIRC	All	All	+0.188	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RNU6ATAC24P–STAD

Open the STAD breakdown →